Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Human Immunology
|
March 1, 2026
Roles of full-length and Δα1 HLA-G isoforms in NK-cell regulation and vascular SARS-CoV-2 infection
G Schiuma, D Tronik-Le Roux, S Beltrami, et al.
European Review for Medical and Pharmacological Sciences
|
February 3, 2022
COVID-19: identifying the main outcome predictors. A retrospective cohort study in Northern Italy
S Greco, B Bonsi, A Bella, et al.
European Review for Medical and Pharmacological Sciences
|
December 1, 2023
From intensive care to rehabilitation: survey on the satisfaction with care received during prolonged hospitalization for COVID-19 at a northern Italian university hospital
S Straudi, N Lamberti, L Baluardo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation
S Peters, S Loi, F André, et al.
ESMO Open
|
November 19, 2025
The risk of lung cancer from vaping or e-cigarette usage: a systematic review
S Mohapatra, A Tiwari, A Kandala, et al.
ESMO Open
|
August 21, 2025
The landscape of conventional and artificial intelligence-based clinical prediction models in non-small-cell lung cancer: from development to real-world validation
H R Howard, M Hasanova, A Tiwari, et al.
ESMO Open
|
April 22, 2021
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
B Gyawali, E G E de Vries, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2025
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)
N I Cherny, S F Oosting, U Dafni, et al.
ESMO Open
|
July 10, 2026
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation
S Peters, M-L Meyer, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2022
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
A Passaro, N Leighl, F Blackhall, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Human Immunology
|
March 1, 2026
Roles of full-length and Δα1 HLA-G isoforms in NK-cell regulation and vascular SARS-CoV-2 infection
G Schiuma, D Tronik-Le Roux, S Beltrami, et al.
European Review for Medical and Pharmacological Sciences
|
February 3, 2022
COVID-19: identifying the main outcome predictors. A retrospective cohort study in Northern Italy
S Greco, B Bonsi, A Bella, et al.
European Review for Medical and Pharmacological Sciences
|
December 1, 2023
From intensive care to rehabilitation: survey on the satisfaction with care received during prolonged hospitalization for COVID-19 at a northern Italian university hospital
S Straudi, N Lamberti, L Baluardo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation
S Peters, S Loi, F André, et al.
ESMO Open
|
November 19, 2025
The risk of lung cancer from vaping or e-cigarette usage: a systematic review
S Mohapatra, A Tiwari, A Kandala, et al.
ESMO Open
|
August 21, 2025
The landscape of conventional and artificial intelligence-based clinical prediction models in non-small-cell lung cancer: from development to real-world validation
H R Howard, M Hasanova, A Tiwari, et al.
ESMO Open
|
April 22, 2021
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
B Gyawali, E G E de Vries, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2025
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)
N I Cherny, S F Oosting, U Dafni, et al.
ESMO Open
|
July 10, 2026
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation
S Peters, M-L Meyer, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2022
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
A Passaro, N Leighl, F Blackhall, et al.
Page
of 7